However, tumor-infiltrating CD8+ T cells and Treg cells express PD-1 at similarly high levels, and the administration of anti-PD-1 antibodies may cause the inadvertent activation of Tregs and the enhancement of immunosuppression [30]. The gene discussed is CD8A; the disease is neoplasm.